Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry

被引:0
|
作者
Iguchi, M. [1 ]
Masunaga, N. [1 ]
Ishii, M. [1 ]
Fujino, A. [1 ]
Ide, Y. [1 ]
Hamatani, Y. [1 ]
Yoshizawa, T. [1 ]
Doi, K. [1 ]
Ikeda, S. [1 ]
Esato, M. [2 ]
Wada, H. [1 ]
Hasegawa, K. [1 ]
Ogawa, H. [1 ]
Abe, M. [1 ]
Akao, M. [1 ]
机构
[1] Natl Hosp Org, Kyoto Med Ctr, Kyoto, Japan
[2] Ogaki Tokushukai Hosp, Gifu, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1041 / 1041
页数:1
相关论文
共 50 条
  • [31] Left atrial fibrosis is associated with new-onset heart failure in patients with atrial fibrillation
    Azadani, Peyman N.
    King, Jordan B.
    Kheirkhahan, Mobin
    Chang, Lowell
    Marrouche, Nassir F.
    Wilson, Brent D.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 : 161 - 165
  • [32] Left Atrial Strain as a Predictor of New-Onset Atrial Fibrillation in Patients With Heart Failure
    Park, Jin Joo
    Park, Jae-Hyeong
    Hwang, In-Chang
    Park, Jun-Bean
    Cho, Goo-Yeong
    Marwick, Thomas H.
    JACC-CARDIOVASCULAR IMAGING, 2020, 13 (10) : 2071 - 2081
  • [33] The Relationship Between History of Valve Surgery and Heart Failure Event in Japanese Atrial Fibrillation Patients: The Fushimi Af Registry
    Doi, Kosuke
    Ishigami, Kenjiro
    Ikeda, Syuhei
    Yoshizawa, Takashi
    Hamatani, Yasuhiro
    Ide, Yuya
    Fujino, Akiko
    Ishii, Mitsuru
    Iguchi, Moritake
    Ogawa, Hisashi
    Masunaga, Nobutoyo
    Wada, Hiromichi
    Hasegawa, Koji
    Abe, Mitsuru
    Akao, Masaharu
    CIRCULATION, 2022, 146
  • [34] Relationship between chronic obstructive pulmonary disease and heart failure hospitalization in patients with atrial fibrillation: the Fushimi AF Registry
    Ishii, M.
    Ishigami, K.
    Ikeda, S.
    Doi, K.
    Yoshizawa, T.
    Hamatani, Y.
    Ide, Y.
    Fujino, A.
    Iguchi, M.
    Masunaga, N.
    Esato, M.
    Wada, H.
    Hasegawa, K.
    Abe, M.
    Akao, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [35] Kidney function and the risk of heart failure in patients with new-onset atrial fibrillation
    Carrero, Juan Jesus
    Trevisan, Marco
    Evans, Marie
    Svennberg, Emma
    Szummer, Karolina
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 320 : 101 - 105
  • [36] Prevention of New-Onset Heart Failure in Atrial Fibrillation: The Role of Pharmacological Management
    Zobdeh, Amirreza
    Hoyle, Daniel J.
    Shastri, Pankti
    Bezabhe, Woldesellassie M.
    Peterson, Gregory M.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (02) : 147 - 155
  • [37] Kidney function and heart failure risk in patients with new-onset atrial fibrillation
    Szummer, K.
    Trevisan, M.
    Evans, M.
    Svennberg, E.
    Carrero, J. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 343 - 344
  • [38] Plasma natriuretic peptide level is an independent determinant of major clinical outcomes in atrial fibrillation patients without heart failure: the Fushimi AF Registry
    Hamatani, Y.
    Iguchi, M.
    Aono, Y.
    Ishigami, K.
    Ikeda, S.
    Doi, K.
    Fujino, A.
    Masunaga, N.
    Esato, M.
    Tsuji, H.
    Wada, H.
    Hasegawa, K.
    Ogawa, H.
    Abe, M.
    Akao, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 673 - 673
  • [39] Response to up-titration of therapies in patients with new-onset heart failure with and without atrial fibrillation
    Zandijk, A. J. L.
    Santema, B. T.
    Van der Wal, M. H. L.
    Warink-Riemersma, J.
    Rienstra, M.
    Voors, A. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 402 - 403
  • [40] Influence of time to ablation on outcomes among patients with atrial fibrillation with pre-existing heart failure
    Lador, Adi
    Maccioni, Sonia
    Khanna, Rahul
    Zhang, Dongyu
    HEART RHYTHM O2, 2024, 5 (09): : 606 - 613